126 related articles for article (PubMed ID: 8443592)
1. Identification of tyrosines 154 and 307 in the extracellular domain and 653 and 766 in the intracellular domain as phosphorylation sites in the heparin-binding fibroblast growth factor receptor tyrosine kinase (flg).
Hou J; McKeehan K; Kan M; Carr SA; Huddleston MJ; Crabb JW; McKeehan WL
Protein Sci; 1993 Jan; 2(1):86-92. PubMed ID: 8443592
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
McKeehan WL; Kan M
Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
[TBL] [Abstract][Full Text] [Related]
3. An essential heparin-binding domain in the fibroblast growth factor receptor kinase.
Kan M; Wang F; Xu J; Crabb JW; Hou J; McKeehan WL
Science; 1993 Mar; 259(5103):1918-21. PubMed ID: 8456318
[TBL] [Abstract][Full Text] [Related]
4. Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants.
Shi E; Kan M; Xu J; Wang F; Hou J; McKeehan WL
Mol Cell Biol; 1993 Jul; 13(7):3907-18. PubMed ID: 8321198
[TBL] [Abstract][Full Text] [Related]
5. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
[TBL] [Abstract][Full Text] [Related]
6. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of K-FGF produces a truncated molecule with increased biological activity and receptor binding affinity.
Bellosta P; Talarico D; Rogers D; Basilico C
J Cell Biol; 1993 May; 121(3):705-13. PubMed ID: 8387532
[TBL] [Abstract][Full Text] [Related]
8. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
Jarvis MF; Gessner GW; Martin GE; Jaye M; Ravera MW; Dionne CA
J Pharmacol Exp Ther; 1992 Oct; 263(1):253-63. PubMed ID: 1383494
[TBL] [Abstract][Full Text] [Related]
9. Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms.
Xu J; Nakahara M; Crabb JW; Shi E; Matuo Y; Fraser M; Kan M; Hou J; McKeehan WL
J Biol Chem; 1992 Sep; 267(25):17792-803. PubMed ID: 1325449
[TBL] [Abstract][Full Text] [Related]
10. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.
Pellegrini L; Burke DF; von Delft F; Mulloy B; Blundell TL
Nature; 2000 Oct; 407(6807):1029-34. PubMed ID: 11069186
[TBL] [Abstract][Full Text] [Related]
12. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis.
Mohammadi M; Dionne CA; Li W; Li N; Spivak T; Honegger AM; Jaye M; Schlessinger J
Nature; 1992 Aug; 358(6388):681-4. PubMed ID: 1379698
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of the Bcl-2-associated protein BNIP-2 by fibroblast growth factor receptor-1 prevents its binding to Cdc42GAP and Cdc42.
Low BC; Lim YP; Lim J; Wong ES; Guy GR
J Biol Chem; 1999 Nov; 274(46):33123-30. PubMed ID: 10551883
[TBL] [Abstract][Full Text] [Related]
14. Determination of the transphosphorylation sites of Jak2 kinase.
Matsuda T; Feng J; Witthuhn BA; Sekine Y; Ihle JN
Biochem Biophys Res Commun; 2004 Dec; 325(2):586-94. PubMed ID: 15530433
[TBL] [Abstract][Full Text] [Related]
15. Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
Lin L; Czerwinski R; Kelleher K; Siegel MM; Wu P; Kriz R; Aulabaugh A; Stahl M
Biochemistry; 2009 Mar; 48(9):2021-32. PubMed ID: 19206206
[TBL] [Abstract][Full Text] [Related]
16. FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation.
Monsonego-Ornan E; Adar R; Rom E; Yayon A
FEBS Lett; 2002 Sep; 528(1-3):83-9. PubMed ID: 12297284
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the conserved acidic amino acid domain of FGF receptor 1 in ligand-receptor interaction.
Chaudhuri MM; Moscatelli D; Basilico C
J Cell Physiol; 1993 Nov; 157(2):209-16. PubMed ID: 8227155
[TBL] [Abstract][Full Text] [Related]
18. Activation of fibroblast growth factor (FGF) receptors by recombinant human FGF-5.
Clements DA; Wang JK; Dionne CA; Goldfarb M
Oncogene; 1993 May; 8(5):1311-6. PubMed ID: 8386828
[TBL] [Abstract][Full Text] [Related]
19. Exon skipping causes alteration of the COOH-terminus and deletion of the phospholipase C gamma 1 interaction site in the FGF receptor 2 kinase in normal prostate epithelial cells.
Yan G; McBride G; McKeehan WL
Biochem Biophys Res Commun; 1993 Jul; 194(1):512-8. PubMed ID: 8333865
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning, overexpression, and characterization of the ligand-binding D2 domain of fibroblast growth factor receptor.
Hung KW; Kumar TK; Chi YH; Chiu IM; Yu C
Biochem Biophys Res Commun; 2004 Apr; 317(1):253-8. PubMed ID: 15047176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
